Immediate Impact
1 by Nobel laureates 53 standout
Citing Papers
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
Mitochondrial dysfunction: mechanisms and advances in therapy
2024 Standout
Works of Larysa Sanchez being referenced
Elotuzumab for the treatment of multiple myeloma
2016
Prognostic factors for brain metastasis in non-small cell lung cancer (NSCLC): A single Institution’s experience for over 10 years.
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Larysa Sanchez | 366 | 326 | 247 | 63 | 572 | |
| Tara Masterson | 422 | 341 | 275 | 42 | 634 | |
| Samer Al Hadidi | 279 | 304 | 199 | 103 | 553 | |
| Maximilian Merz | 313 | 239 | 352 | 52 | 642 | |
| Lan Deng | 203 | 233 | 208 | 53 | 569 | |
| Naresh Bumma | 214 | 257 | 271 | 65 | 516 | |
| Sandhya Nair | 195 | 121 | 141 | 50 | 616 | |
| Natalia Tovar | 359 | 174 | 386 | 53 | 541 | |
| Sandra Sauer | 313 | 215 | 204 | 54 | 553 | |
| Miles Prince | 261 | 251 | 282 | 48 | 634 | |
| Charlotte Lemech | 105 | 364 | 252 | 60 | 648 |
All Works
Login with ORCID to disown or claim papers
Loading papers...